We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

Viad Corp, a public company, has entered into a definitive agreement with private Los Angeles-based private equity firm ...

Jason Zemansky’s rating is based on a nuanced analysis of ... Market dominance by competitors like Merck and recent clinical disappointments have raised questions about dom’s potential to be a profit ...

Le-Vel, the world leader in premium nutrition and lifestyle products, has generously donated approximately 64,000 of its meal ...

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage's Chief Executive ...

Most of the rise in Treasury yields is due to U.S. economic data coming in stronger than anticipated, with the unemployment rate actually falling while inflation has been stubbornly resilient. The ...

Directed and written by Perry (“Her Smell”), “Pavements” stars Joe Keery, Jason Schwartzman ... Dave Ayers, Sara Lord, Merck Mercuriadis, Betsy Hershey, Michael Karbelnikoff, Robert ...

In agreement is Jason K. Hou, MD, MS ... The study was supported by Prometheus Biosciences, a subsidiary of Merck. Sands disclosed multiple ties to private companies, including research support ...

With both techniques, disease control rates were over 90%, with virtually no difference in bowel function or other quality-of-life ratings after 2 years, reported Jason Efstathiou, MD, PhD ...

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...